Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123438584 | 12343858 | 4 | F | 20160624 | 20160507 | 20160708 | EXP | US-AUROBINDO-AUR-APL-2016-05692 | AUROBINDO | 37.00 | YR | F | Y | 0.00000 | 20160708 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123438584 | 12343858 | 1 | PS | Vancomycin | VANCOMYCIN | 1 | Intraperitoneal | 500-MG LOADING DOSE | Y | U | 205779 | 500 | MG | ||||||
| 123438584 | 12343858 | 2 | SS | Vancomycin | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | ONE TIME LOADING DOSE | Y | U | 205779 | 1 | G | ||||||
| 123438584 | 12343858 | 3 | SS | Vancomycin | VANCOMYCIN | 1 | Intraperitoneal | 50 MG PER BAG (25MG/L) EVERY SIX HOURS | Y | U | 205779 | 50 | MG | ||||||
| 123438584 | 12343858 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, UNK | U | 0 | 5 | MG | |||||||
| 123438584 | 12343858 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 10 MG, AT BEDTIME | U | 0 | 10 | MG | |||||||
| 123438584 | 12343858 | 6 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Oral | 750 MG, UNK | U | 0 | 750 | MG | |||||||
| 123438584 | 12343858 | 7 | C | DOCUSATE | DOCUSATE | 1 | Oral | 100 MG, AS NEEDED | U | 0 | 100 | MG | |||||||
| 123438584 | 12343858 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 5 MG, UNK | U | 0 | 5 | MG | |||||||
| 123438584 | 12343858 | 9 | C | POLYETHYLENE GLYCOL 3350. | POLYETHYLENE GLYCOL 3350 | 1 | Oral | 17 G, UNK | U | 0 | 17 | G | |||||||
| 123438584 | 12343858 | 10 | C | MEROPENEM. | MEROPENEM | 1 | Intravenous (not otherwise specified) | 1 G I.V. EVERY 24 HOURS, TO BE INFUSED OVER 4 HOURS. | U | 0 | 1 | G |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123438584 | 12343858 | 1 | Bacterial infection |
| 123438584 | 12343858 | 4 | Product used for unknown indication |
| 123438584 | 12343858 | 5 | Product used for unknown indication |
| 123438584 | 12343858 | 6 | Product used for unknown indication |
| 123438584 | 12343858 | 7 | Constipation |
| 123438584 | 12343858 | 8 | Product used for unknown indication |
| 123438584 | 12343858 | 9 | Product used for unknown indication |
| 123438584 | 12343858 | 10 | Peritonitis bacterial |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123438584 | 12343858 | OT |
| 123438584 | 12343858 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123438584 | 12343858 | Abdominal pain | |
| 123438584 | 12343858 | Condition aggravated | |
| 123438584 | 12343858 | Decreased appetite | |
| 123438584 | 12343858 | Hypotension | |
| 123438584 | 12343858 | Neutrophilia | |
| 123438584 | 12343858 | Noninfectious peritonitis | |
| 123438584 | 12343858 | Tenderness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |